Synthesis and biological evaluation of 4-quinazolinones as Rho kinase inhibitors
2011
Rho kinase (ROCK) is an attractive therapeutic target for various diseases including glaucoma, hypertension, and spinal cord injury. Herein, we report the development of a series of ROCK-II inhibitors based on 4-quinazolinone and quinazoline scaffolds. SAR studies at three positions of the quinazoline core led to the identification of analogs with high potency against ROCK-II and good selectivity over protein kinase A (PKA).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
20
References
25
Citations
NaN
KQI